Atogepant

Generic name: Atogepant (a Toe' Je Pant)
Brand names: Qulipta
Dosage form: Tablet (10 mg; 30 mg; 60mg)
Drug class: CGRP inhibitors

Usage of Atogepant

Atogepant (Qulipta) is a prescription medicine used for the preventive treatment of episodic migraine in adults. Atogepant is CGRP inhibitor (calcitonin gene-related peptide receptor antagonist) that works by blocking a small protein (CGRP) in the body that is involved with migraines and pain.

Atogepant has been shown in clinical trials to reduce the number of monthly migraines, the number of monthly headache days, and decrease the number of days patients had to take other medicines to treat migraines.

Atogepant is a once-a-day tablet that is FDA approved to prevent episodic migraine headaches in adults.

Atogepant side effects

Common atogepant side effects may include:

constipation,

nausea, and

fatigue.

This is not all of the possible side effects of atogepant. Talk with doctor, pharmacist or health professional for medical advice about side effects. Side effects may be reported to FDA at 1-800-FDA-1088.

Before taking Atogepant

Tell your healthcare provider about all of your medical conditions before you take atogepant, this includes if you:

have problems with your liver.

have problems with your kidneys or are on dialysis.

are planning to become pregnant or are pregnant, as it is not known if this medicine will harm your unborn baby.

are planning to breastfeed or are breastfeeding as it is not known if this medicine passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking this medicine.

are allergic to atogepant, or any of the ingredients in atogepant tablets. A list of ingredients in Qulipta brand of atogepant is below.

Relate drugs

How to use Atogepant

Qulipta brand of atogepant is available as 10 mg, 30 mg, or 60 mg tablets. The usual adult dose for preventive treatment of migraine is:

10 mg, 30 mg, or 60 mg taken orally once daily and can be taken with or without food.

The dose you are prescribed may depend on your kidney function and any other medications you take. See below “What other drugs will affect atogepant?”

What happens if I miss a dose?

If you miss a dose take your tablet as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

What happens if I overdose?

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at Poison Help. If the victim has collapsed, has trouble breathing, had a seizure, or can't be awakened, immediately call emergency services at 911.

What other drugs will affect Atogepant

Tell your doctor, pharmacist, or healthcare provider about any other prescription, over-the-counter medicines, vitamins, and nutritional supplements you are taking, planning to take, or if you are stopping or reducing the dose of these products.

Medications and other products may interact with atogepant. Your doctor may need to change the doses of your medications or monitor you carefully for side effects depending on what other products you are taking.

It is very important to tell your healthcare provider of any of these medications:

ketoconazole or itraconazole

cyclosporine

clarithromycin

rifampin

carbamazepine

phenytoin

St. John’s wort

efavirenz

etravirine

This is not a complete list of drug interactions with atogepant. Not all possible interactions are listed here.

Popular FAQ

Ubrelvy, Qulipta and Nurtec ODT are all medicines used by adults for migraines. They are all from the same group of medicines often called gepants but their full name is calcitonin gene-related peptide (CGRP) receptor antagonist. Continue reading

Qulipta (generic name: atogepant) did not lead to hair loss (alopecia) during clinical trials submitted for FDA-approval. Qulipta is an oral CGRP receptor antagonist (gepant) used to help prevent migraine headache pain. Hair loss is not listed as a side effect in its FDA-approved product label. Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.